Clinical trial Recruiting at 1 site Observational Ages 18 and up

Bilateral cervical sympathetic blocks with optional integrative therapy for Special Operations veterans with PTSD and trauma-related symptoms

Official title: Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospective Case Series.

Run by Reset Medical and Wellness Center · NCT07473505 · Data updated 2026-11-12

This project will try bilateral cervical sympathetic blocks (BCSB), with or without added structured integrative therapy, to see if they reduce PTSD, TBI, and other trauma-related symptoms in Special Operations veterans.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment75 (estimated)
SponsorReset Medical and Wellness Center
Academic / other
Locations1 site (Strongsville, Ohio)
StatusRecruiting
StartedMarch 20, 2026
Main results expectedFebruary 24, 2027
Study endsJuly 1, 2027
Registry record updatedMarch 20, 2026
Trial IDNCT07473505 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult Special Operations Forces veterans with PTSD (PCL score ≥33), fluent in English, willing to provide informed consent and complete study procedures, and seeking BCSB treatment are ideal candidates.

Probably not a fit

Patients who received any cervical sympathetic block in the past 6 months, have acute psychiatric instability, have medical contraindications to BCSB, or are enrolled in other interventional trials are unlikely to benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational case series enrolling Special Operations Forces veterans who independently seek bilateral cervical sympathetic blocks as part of routine care. Participants receive BCSB using standardized FDA‑approved dosing of 0.5% ropivacaine, and outcomes are compared between those who receive BCSB alone versus BCSB plus structured integrative therapy. Validated symptom measures for PTSD, TBI, anxiety, and moral injury are administered alongside strict safety monitoring. Clinical procedures are performed at RESET Medical and Wellness Center and recruitment occurs through the Operator Relief Fund intake flow without altering clinical decision-making.

Why it matters

Potential benefit: If successful, this approach could reduce PTSD and TBI-related symptoms and may provide longer-lasting symptom relief when paired with structured integrative therapy.

How similar studies have gone: Related procedures such as unilateral stellate ganglion block have shown some promising early results for PTSD symptoms, but randomized long‑term evidence is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or older
* PTSD (PCL Score of 33 or greater at baseline screening)
* Willing and able to provide informed consent and complete study procedures
* Fluent in English
* Special Operations Forces Veteran

Exclusion Criteria:

* Recent Sympathetic Block: Receipt of any cervical sympathetic block (including stellate ganglion block \[SGB\], dual sympathetic ganglion block \[DSGB\], or bilateral SGB/BCSB), whether unilateral or bilateral, within the past 6 months.
* Concurrent interventional clinical trial participation: Currently enrolled in another interventional clinical trial or receiving any experimental treatment targeting PTSD, TBI, or autonomic dysfunction during the study period
* Acute Psychiatric Instability: Currently experiencing acute psychiatric crisis requiring inpatient care, active suicidal or homicidal intent, or untreated mania, psychosis, or severe dissociation
* Medical Contraindications to BCSB: Any known anatomical abnormalities, bleeding disorders, allergy to local anesthetics, pregnancy, or comorbidities that represent a contraindication to receiving a cervical sympathetic block, per the treating physician's judgment.
* Language or communication barriers: Inability to read, speak, or understand English sufficiently to complete informed consent and study assessments
* Low PTSD Symptom Severity at Baseline: PCL-5 Score \< 33 at screening, indicating subclinical or minimal PTSD symptoms (Rationale: to ensure measurable clinical benefit and reduce floor effects)

Where it's running

  • Reset Medical and Wellness Center
    Strongsville, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.